Copyright Reports & Markets. All rights reserved.

Global Cardiac Troponin Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Cardiac Troponin Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cardiac Troponin Market Size Growth Rate by Product
      • 1.4.2 Laboratory Testing
      • 1.4.3 Point-of-care Testing
    • 1.5 Market by End User
      • 1.5.1 Global Cardiac Troponin Market Size Growth Rate by End User
      • 1.5.2 Acute Coronary Syndrome
      • 1.5.3 Myocardial Infarction
      • 1.5.4 Congestive Heart Failure
      • 1.5.5 Others Applications
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cardiac Troponin Market Size
      • 2.1.1 Global Cardiac Troponin Revenue 2014-2025
      • 2.1.2 Global Cardiac Troponin Sales 2014-2025
    • 2.2 Cardiac Troponin Growth Rate by Regions
      • 2.2.1 Global Cardiac Troponin Sales by Regions
      • 2.2.2 Global Cardiac Troponin Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cardiac Troponin Sales by Manufacturers
      • 3.1.1 Cardiac Troponin Sales by Manufacturers
      • 3.1.2 Cardiac Troponin Sales Market Share by Manufacturers
      • 3.1.3 Global Cardiac Troponin Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cardiac Troponin Revenue by Manufacturers
      • 3.2.1 Cardiac Troponin Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cardiac Troponin Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cardiac Troponin Price by Manufacturers
    • 3.4 Cardiac Troponin Manufacturing Base Distribution, Product Types
      • 3.4.1 Cardiac Troponin Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cardiac Troponin Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cardiac Troponin Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cardiac Troponin Sales by Product
    • 4.2 Global Cardiac Troponin Revenue by Product
    • 4.3 Cardiac Troponin Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cardiac Troponin Breakdown Data by End User

    6 North America

    • 6.1 North America Cardiac Troponin by Countries
      • 6.1.1 North America Cardiac Troponin Sales by Countries
      • 6.1.2 North America Cardiac Troponin Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cardiac Troponin by Product
    • 6.3 North America Cardiac Troponin by End User

    7 Europe

    • 7.1 Europe Cardiac Troponin by Countries
      • 7.1.1 Europe Cardiac Troponin Sales by Countries
      • 7.1.2 Europe Cardiac Troponin Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cardiac Troponin by Product
    • 7.3 Europe Cardiac Troponin by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cardiac Troponin by Countries
      • 8.1.1 Asia Pacific Cardiac Troponin Sales by Countries
      • 8.1.2 Asia Pacific Cardiac Troponin Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cardiac Troponin by Product
    • 8.3 Asia Pacific Cardiac Troponin by End User

    9 Central & South America

    • 9.1 Central & South America Cardiac Troponin by Countries
      • 9.1.1 Central & South America Cardiac Troponin Sales by Countries
      • 9.1.2 Central & South America Cardiac Troponin Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cardiac Troponin by Product
    • 9.3 Central & South America Cardiac Troponin by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cardiac Troponin by Countries
      • 10.1.1 Middle East and Africa Cardiac Troponin Sales by Countries
      • 10.1.2 Middle East and Africa Cardiac Troponin Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cardiac Troponin by Product
    • 10.3 Middle East and Africa Cardiac Troponin by End User

    11 Company Profiles

    • 11.1 Abbott Diagnostics
      • 11.1.1 Abbott Diagnostics Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Abbott Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Abbott Diagnostics Cardiac Troponin Products Offered
      • 11.1.5 Abbott Diagnostics Recent Development
    • 11.2 Roche
      • 11.2.1 Roche Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Roche Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Roche Cardiac Troponin Products Offered
      • 11.2.5 Roche Recent Development
    • 11.3 bioMrieux
      • 11.3.1 bioMrieux Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 bioMrieux Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 bioMrieux Cardiac Troponin Products Offered
      • 11.3.5 bioMrieux Recent Development
    • 11.4 BG Medicine
      • 11.4.1 BG Medicine Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 BG Medicine Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 BG Medicine Cardiac Troponin Products Offered
      • 11.4.5 BG Medicine Recent Development
    • 11.5 Ortho Clinical Diagnostics
      • 11.5.1 Ortho Clinical Diagnostics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Ortho Clinical Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Ortho Clinical Diagnostics Cardiac Troponin Products Offered
      • 11.5.5 Ortho Clinical Diagnostics Recent Development
    • 11.6 Singulex
      • 11.6.1 Singulex Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Singulex Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Singulex Cardiac Troponin Products Offered
      • 11.6.5 Singulex Recent Development
    • 11.7 Alere
      • 11.7.1 Alere Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Alere Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Alere Cardiac Troponin Products Offered
      • 11.7.5 Alere Recent Development
    • 11.8 Siemens Healthcare Diagnostics
      • 11.8.1 Siemens Healthcare Diagnostics Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Siemens Healthcare Diagnostics Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Siemens Healthcare Diagnostics Cardiac Troponin Products Offered
      • 11.8.5 Siemens Healthcare Diagnostics Recent Development
    • 11.9 Beckman Coulter
      • 11.9.1 Beckman Coulter Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Beckman Coulter Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Beckman Coulter Cardiac Troponin Products Offered
      • 11.9.5 Beckman Coulter Recent Development
    • 11.10 LifeSign
      • 11.10.1 LifeSign Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 LifeSign Cardiac Troponin Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 LifeSign Cardiac Troponin Products Offered
      • 11.10.5 LifeSign Recent Development

    12 Future Forecast

    • 12.1 Cardiac Troponin Market Forecast by Regions
      • 12.1.1 Global Cardiac Troponin Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cardiac Troponin Revenue Forecast by Regions 2019-2025
    • 12.2 Cardiac Troponin Market Forecast by Product
      • 12.2.1 Global Cardiac Troponin Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cardiac Troponin Revenue Forecast by Product 2019-2025
    • 12.3 Cardiac Troponin Market Forecast by End User
    • 12.4 North America Cardiac Troponin Forecast
    • 12.5 Europe Cardiac Troponin Forecast
    • 12.6 Asia Pacific Cardiac Troponin Forecast
    • 12.7 Central & South America Cardiac Troponin Forecast
    • 12.8 Middle East and Africa Cardiac Troponin Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cardiac Troponin Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis.
      Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents the susceptibility of myocardial infarction.
      The global Cardiac Troponin market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Troponin market based on company, product type, end user and key regions.

      This report studies the global market size of Cardiac Troponin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Troponin in these regions.
      This research report categorizes the global Cardiac Troponin market by top players/brands, region, type and end user. This report also studies the global Cardiac Troponin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Abbott Diagnostics
      Roche
      bioMrieux
      BG Medicine
      Ortho Clinical Diagnostics
      Singulex
      Alere
      Siemens Healthcare Diagnostics
      Beckman Coulter
      LifeSign

      Market size by Product
      By end user
      Laboratory Testing
      Point-of-care Testing
      By product
      cTn T
      cTn I
      TnC
      Market size by End User
      Acute Coronary Syndrome
      Myocardial Infarction
      Congestive Heart Failure
      Others Applications

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cardiac Troponin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cardiac Troponin market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cardiac Troponin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cardiac Troponin submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cardiac Troponin are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Troponin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now